Question 1

How many shares of SYRE does Carlyle Group Inc. own?

Accepted Answer

Carlyle Group Inc. previously held 0 shares of SYRE (Spyre Therapeutics, Inc) before exiting the position in 2026-Q2.

Question 2

What is Carlyle Group Inc.'s SYRE position worth?

Accepted Answer

Carlyle Group Inc.'s SYRE position was last reported at $0 in 2026-Q2 before the exit.

Question 3

Is Carlyle Group Inc. buying or selling SYRE?

Accepted Answer

In 2026-Q2, Carlyle Group Inc. exited their SYRE position entirely (-100.0% change in shares).

Question 4

When did Carlyle Group Inc. first buy SYRE?

Accepted Answer

Based on available 13F filings, Carlyle Group Inc. first reported a position in SYRE in 2024-Q3. They have held the position across 9 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$88.78	0
2026-Q1	Unchanged	9,620	0.0%	$485,233	0.0%	$40.07	0
2025-Q4	New	9,620	—	$315,055	0.0%	$31.88	36
2025-Q1	Exited	0	-100.0%	$0	0.0%	$17.94	0
2024-Q4	Unchanged	9,620	0.0%	$223,761	0.0%	$22.54	0
2024-Q3	Unchanged	9,620	0.0%	$282,443	0.0%	$28.49	0